Delivery Order 75F40125D00022-75F40126F19002
Award Date 8/14/26
Potential Completion Date 8/13/27
Potential Value $150K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration issued a delivery order to Somalogic Operating Co., Inc. on May 13, 2024, with a ceiling value of $33,600 under IDIQ contract 75F40120D00018 for proteomics analysis of human plasma. Place of performance is Boulder, CO. The order is firm fixed price with an ultimate completion date of August 31, 2025. Work involves advanced protein measurement and biomarker discovery using the company's proprietary SomaScan platform, which simultaneously measures up to 11,000...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., for the SOMASCAN V4.1 PLASMA/HUMAN, EDTA PLASMA/SOMASCAN DISCOVERY DELIVERING V4.1 7K PROTEIN MEASUREMENT FROM PLASMA. The $40,000.00 firm-fixed-price contract has a period of performance through July 31, 2023. Somalogic, a commercial-stage proteomics company, will provide protein measurement services using its proprietary SomaScan platform to...
- The Food and Drug Administration issued a $273,650 delivery order to Somalogic Operating Co., Inc. on September 23, 2025, for genomic services with an ultimate completion date of March 31, 2027. This is a firm fixed price order under an FDA indefinite delivery/indefinite quantity contract. Place of performance is Silver Spring, MD. The modification increases the contract ceiling, extends the period of performance, and incorporates FAR 52.222-90 and Executive Order 14398 into the contract. No...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract is for the provision of multiplex aptamer-based assay kits, with a ceiling value of $339,913.40 and a completion date of November 14, 2016. The contract is designated as a Total Small Business set-aside. Somalogic is a commercial-stage proteomics company that provides advanced protein measurement and biomarker...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Delivery Order contract to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., for $213,200.00. The contract is for proteomics analysis of human plasma samples using Somalogic's proprietary SomaScan platform, which measures thousands of proteins in small biospecimens. This work supports the FDA's regulatory review and evaluation of medical products. The contract has a...
- This task order, awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA), calls for $470,000 in proteomics analysis services of human serum or plasma from Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The firm fixed price delivery order has a period of performance through August 31, 2022 and was awarded on September 30, 2020 without a set-aside designation. The place of performance will be Silver Spring, Maryland, where the HHS...
- This federal contract award to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., was issued by the Food and Drug Administration (FDA) on June 9, 2015. The $144,500.00 firm-fixed-price purchase order is for the measurement of proteins in mouse EDTA plasma samples. The contract has a total small business set-aside designation and an ultimate completion date of October 7, 2015. Somalogic, a commercial-stage proteomics company, provides advanced protein measurement and...
- The Department of Health and Human Services Food and Drug Administration awarded a $40,000 firm fixed price delivery order against its IDIQ contract for Proteomics of Human Plasma and/or Serum. Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., will provide plasma proteomic assay services per sample under the terms of this order. Performance will take place in Silver Spring, Maryland through August 31, 2022. No set-aside designation was applied to this award made in...
- The U.S. Office of Logistics and Acquisition Operations awarded a $58.8K firm fixed-price purchase order to SomaLogic Operating Co., Inc. (doing business as CM Life Sciences II Inc.) on April 29, 2021, with completion targeted for July 31, 2021. The contract covers SomaScan assays and SomaSignal tests utilizing SomaLogic's innovative 7,000-analyte multiplex proteomics platform service, to be performed at the contractor's facility in Boulder, Colorado. This award does not utilize a set-aside...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,501,831.62 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. This order is for SomaScan assay kits and reagents to be delivered by June 22, 2023. Somalogic is a commercial-stage proteomics company that provides protein biomarker discovery and diagnostic services through its proprietary SomaScan...